Importantly, TNF-α may be associated with disease severity; more advanced phenotypes (i.e., NASH or NAFLD-related cirrhosis) seem to be associated with higher circulating TNF-α, which may also link NAFLD with extrahepatic manifestations, such as CVD and malignancies. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.